首页> 外文期刊>Shiraz University of Medical Sciences >Oral Administration of Vitamin C, Cimetidine and Famotidine on Micronuclei Induced by Low Dose Radiation in Mouse Bone Marrow Cells
【24h】

Oral Administration of Vitamin C, Cimetidine and Famotidine on Micronuclei Induced by Low Dose Radiation in Mouse Bone Marrow Cells

机译:口服维生素C,西咪替丁和法莫替丁对小鼠骨髓细胞低剂量辐射诱导的微核的口服

获取原文
           

摘要

?? Background: In many studies, chemicals and natural materials were tested to reduce the harmful effects of radiation. It is known that Famotidine and vitamin C reduce DNA damage. Objective: The aim of this study was to evaluate the radioprotective effect of vitamin C, Cimetidine and Famotidine on gamma-radiation-induced damage on mouse bone marrow.?? Methods: Six-to-seven week male NMRI mice (28 g ?±3) were randomly divided into fourteen groups: control, 2Gy irradiation, six group drugs without irradition (Famotidine, Cimetidine, vitaminC, Fam-Cim, Fam-Vit, Cim-Vit), six groups received drugs and 2Gy radiation with a 60Co |?3|-ray source at room temperature 22 ?± 2 ?°C. The mice were killed 48 hours after irradiation by cervical dislocation. Slides were prepared from bone marrow cells and stained in May-Granwald and Giemsa. Finally, the cells were counted with microscope, frequencies of polychromatic erythrocyte (PCE), normochoromatic erythrocyte (NCE) and their micronuclated cell were recorded. PCE / PCE + NCE were calculated.?? Results: There were significant differences of MNPCE/1000PCE, MNNCE/1000NCE and PCE/PCE+NCE among different groups with similar radiation doses (pa?¤0.01). Moreover, there were significant differences of MNPCE/1000PCE and PCE/PCE+NCE among different doses of radiation (pa?¤0.01). While considering MNNCE/1000NCE, there were no significant differences among silimar groups with radiation dose (p??0.05). Conclusion: Oral administration of Famotidine, vitamin C and Cimetidine demonstrate reliable and similar radioprotective effects. Additionally, the protective effect of single use of these drugs was similar to the combination form. Thus, the oral use of combination, 48 hours after irradiation cannot induce more radioprotective effect. ?? ??.
机译:??背景:在许多研究中,对化学物质和天然材料进行了测试,以减少辐射的有害影响。已知法莫替丁和维生素C可减少DNA损伤。目的:本研究的目的是评估维生素C,西咪替丁和法莫替丁对γ射线辐射引起的小鼠骨髓损伤的放射防护作用。方法:将六至七周的雄性NMRI小鼠(28 g±±3)随机分为14组:对照组,2Gy辐射,六种无辐射药物(法莫替丁,西咪替丁,维生素C,Fam-Cim,Fam-Vit, (Cim-Vit),六组患者在室温22°C±2°C下用60Co |?3 |射线源接受药物和2Gy辐射。照射后48小时通过颈脱位法处死小鼠。从骨髓细胞制备载玻片,并在May-Granwald和Giemsa中染色。最后,用显微镜对细胞计数,记录多色红细胞(PCE),正常色性红细胞(NCE)的频率及其微核细胞。计算PCE / PCE + NCE。结果:在辐射剂量相似的不同组之间,MNPCE / 1000PCE,MNNCE / 1000NCE和PCE / PCE + NCE之间存在显着差异(pa?0.01)。此外,不同剂量的放射线之间,MNPCE / 1000PCE和PCE / PCE + NCE之间存在显着差异(pa?¤0.01)。在考虑MNNCE / 1000NCE的情况下,骨组之间的辐射剂量没有显着差异(p ?? 0.05)。结论:口服法莫替丁,维生素C和西咪替丁具有可靠且相似的放射防护作用。另外,这些药物的单次使用的保护作用类似于联合用药形式。因此,在辐射后48小时口服组合使用不能引起更多的辐射防护作用。 ?? ??。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号